Emergent BioSolutions Inc. (EBS) Stock Profile — Insider Trades & Financials

Revenue$148.7M

Net Income-$54.6M

EPS$0.93

Market Cap$406.4M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Joseph C. Papa

CEO & Executive Director

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.

Employees: 1,600
Headquarters: GAITHERSBURG, MD, United States
Website: www.emergentbiosolutions.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-10.45%

ROA?

-4.14%

D/E Ratio?

1.52

Op. Margin?

-18.76%

📊

Profitability Ratios

Net Margin?

-36.72%

Loading company sections...

Emergent BioSolutions Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness